Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in people with diabetes with no available treatment. AIM: To explore the effect of testosterone treatment on liver. Testosterone therapy improves insulin resistance and reduces total body fat, but its impact on the liver remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolov, Ross, Gianatti, Emily, Wong, Darren, Kutaiba, Numan, Gow, Paul, Grossmann, Mathis, Sinclair, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099110/
https://www.ncbi.nlm.nih.gov/pubmed/35646271
http://dx.doi.org/10.4254/wjh.v14.i4.754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099110/
https://www.ncbi.nlm.nih.gov/pubmed/35646271
http://dx.doi.org/10.4254/wjh.v14.i4.754

Ejemplares similares